The Evaluation of Hepatitis C Virus Core Antigen in Immunized Balb/C Mice
Hepatitis Monthly: ,
12 (6); 391-397 Article Type: Research Article
February 16, 2012
April 20, 2012
A, et al. The Evaluation of Hepatitis C Virus Core Antigen in Immunized Balb/C Mice,
Online ahead of Print
Background: Hepatitis infection represents one of the important causes of morbidity and mortality in developing countries, however there is not any effective vaccine against hepatitis C which is one of the significant problems in vaccine project. Objectives: The aim of the present study is to evaluate the role of HCV core protein in inducing IFN-Gamma secretion and TCL activities as a vaccine in Balb/C mice. Material and Methods: Our previous cloned plasmid (HCV Core gene into pETDuet-1) applied for protein expression in bacteria. The expressed and purified recombinant protein together with Freund’s adjuvant was injected to 15 Balb/c mice. The total IgG and IgG2a of immunized mice sera were evaluated after a week. Two weeks after booster injection, we studied the proliferation and IFNγ secretion of spleens, inguinal and popliteal lymph nodes lymphocytes by ELISA and ELISPOT. Results: The FSFC (Frequency of spot forming cells) of secreting cells of immunized mice with HCV/Core protein and sera IgG2a were considerably higher than the control groups. Conclusions: The core protein together with proper adjuvant can be a candidate vaccine against of HCV infection.
Implication for health policy/practice/research/medical education: This study has implication for further researches and vaccine development and it is also useful for medical researchers and education specially immunologists. Please cite this paper as: Torbati E, Bandehpour M, Pakzad P, Mosaffa N, Kazemi B. The Evaluation of Hepatitis C Virus Core Antigen in Immunized Balb/C Mice. Hepat Mon. 2012;12(6): 391-397. DOI: 10.5812/hepatmon.6141
Copyright © 2012 Kowsar Corp. All rights reserved.
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.